Interviews

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses key considerations for treating delirium in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses sleep's role in treating patients in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what he's learned from using sedation for pain and delirium in critically ill patients.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses delirium risk factors pharmacists should consider when handling patients in the ICU.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how her organization has handled investigational agents in pharmacy workflow.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses which non-pharmacologic treatments pharmacists should consider when caring for patients in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses key concepts pharmacists should consider when selecting sedatives, analgesics, and antipsychotics for critically ill patients.

Hae Mi Choe, PharmD, explains how metrics and tools create areas of opportunity for pharmacists.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses how pharmacists can help detect delirium in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses current practice guidelines for pain and delirium that would be important for pharmacists.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what elements pharmacists should consider when detecting delirium in the ICU.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how pharmacists can rationalize the need to compound or import drugs that are in short supply.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses current attitudes regarding drug-induced coma in the ICU.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in copay and reimbursement assistance that specialty pharmacies need to be aware of.

Hae Mi Choe, PharmD, describes how pharmacists can use metrics for reimbursement recognition.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how strategies to mitigate drug shortages can lead to medication errors.

Hae Mi Choe, PharmD, details the types of reimbursement processes available for clinical pharmacy services.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how pharmacists can help avoid drug shortages.

Hae Mi Choe, PharmD, describes how pharmacists can help ensure consistency across health care providers.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how pharmacists can manage during drug shortages.

Hae Mi Choe, PharmD, describes the challenges associated with metrics and tools for health-system pharmacy.

Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses what areas pharmacists should focus on during acute stroke codes.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how strategies to mitigate drug shortages can threaten patient safety.

Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.

Binita Patel, PharmD, MS, explains the role telehealth and telepharmacy will play in patient management.

Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses how pharmacists can enhance stroke care.

Binita Patel, PharmD, MS, discusses how provider status would affect reimbursement models in ambulatory pharmacy.

Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses measures of gauging stroke.

Thomas Morrow, MD, chief medical officer at Next IT, discusses hurdles that specialty pharmacies need to overcome.

Binita Patel, PharmD, MS, discusses how pharmacists can prepare for threats to the current ambulatory care model.